Decoding cancer’s camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade
Open Access
- 1 January 2020
- journal article
- review article
- Published by OAE Publishing Inc. in Cancer Drug Resistance
- Vol. 3 (4) , 832-853
Abstract
Cancer Drug Resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. Both clinical and experimental aspects of drug resistance in cancer are included.Keywords
This publication has 173 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and InvasionCancer Cell, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- The Hallmarks of CancerCell, 2000